$ICU

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference - SeaStar Medical Holding (NASDAQ:ICU)

DENVER, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- SeaStar Medical Holding Corporation ( NASDAQ:ICU ) , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that Eric Schlorff, Chief ...

Original reporting
Benzinga · Globe Newswire
Published Nov 20, 2025, 2:52 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 21, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference - SeaStar Medical Holding (NASDAQ:ICU) — source image
Decision brief

The 30-second read

$ICUNeutralLow
01

Why it matters

Investor presentations can boost visibility but do not guarantee immediate stock price changes; market reaction depends on the content and investor perception.

02

Market read

The event is relevant for current and prospective investors but has limited immediate trading implications.

03

What to watch

Potential upcoming financial results or clinical trial data could have a more substantial impact than the conference presentation.

Timing: short-term

Background

SeaStar Medical is a healthcare company focusing on treatments for organ failure, actively engaging with investors through conferences.

Company-level read

Ticker impact

$ICUNeutralMedium confidence
Context

The news pertains directly to SeaStar Medical Holding Corporation (NASDAQ:ICU), indicating potential company-specific developments.

Expected impact

Limited immediate price movement expected; potential for moderate positive movement if the presentation garners investor interest.

Evidence & confidence

The announcement indicates ongoing corporate activities but lacks immediate financial data or product updates that could significantly influence stock price.

Market effects

The healthcare sector, especially companies involved in critical care treatments, may see increased investor attention.

Limited regional impact; primarily relevant to US markets where the company is listed.

Minimal global market impact given the company's size and the event's nature.

Counterpoint

The presentation may be a routine event with no significant new information, leading to negligible stock movement.

Key entities

  • SeaStar Medical Holding Corporation

    A healthcare company developing treatments for critically ill patients.

  • NobleCon21

    An event where companies present to investors, potentially influencing investor sentiment.

Related articles

$ICUMed

SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript

SeaStar Medical Holding Corp (ICU) reported Q2 2026 net revenue of $615,000, up 82% year over year, and six-month net revenue of $1.1 million. Gross margin was 91%. Net loss was $3.7 million ($0.91/share). Cash was $7.0 million at June 30, 2026. QUELIMMUNE adoption reached 20 hospitals; NEUTRALIZE-AKI enrolled 223/339 patients.

$ICUMed

SeaStar Medical Holding Corp (ICU): Results of Operations and Financial Condition

SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973548.htm EXHIBIT 99.1 - Q1 2026 EARNINGS RELEASE ex_973548.htm Exhibit 99.1 SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates Added 3 top-rated children ’ s hospitals to QUELIMMUNE ® pediatric acute kidney injury (AKI) cust

$RIOTHighAI 9/10

Anthropic Just Paid $9 Billion to Rent a Bitcoin Miner's Power Grid

Anthropic, the developer of Claude, agreed with Riot Platforms to lease 191 MW of computing capacity at Riot’s Rockdale, Texas site for $9.1 billion over 20 years through June 2048, with two five-year extension options that could raise total value to $16.1 billion, according to Riot’s regulatory filing. RIOT shares rose over 25% after the disclosure.

$BAMed

US jury awards $29 mn damages to Boeing 737 MAX victim's family

A Chicago jury awarded $29 million in damages to the family of Naoise Connolly Ryan, widow of UN engineer Michael Ryan, who died in the 2019 Boeing 737 MAX crash. The civil suit was filed against Boeing. The article notes Boeing apologized and said anti-stall software was implicated. It cites another $49.5 million award in May.

$BAMed

Jury awards $29m to Irishman's family after plane crash

A Chicago jury awarded $29m to the family of Naoise Connolly Ryan, widow of UN employee Micheál “Mick” Ryan, who died in the 2019 Boeing 737 MAX crash. The civil suit was filed against Boeing. Boeing has apologized and said anti-stall software was implicated. The case is among remaining MAX civil suits.

$RIOTMed

B. Riley keeps Riot at Buy after $9.1 billion Rockdale AI lease

B. Riley Securities reiterated a Buy rating and $28 price target for Riot Platforms (RIOT), citing a 20-year Rockdale, Texas AI data center lease. The initial 191 MW lease is expected to generate about $9.1 billion in contract revenue through June 2048. Riot reported Q2 revenue of $174.2 million (+14% YoY) and expects MW to come online from Dec 2027 to June 2028.